The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2023
DOI: 10.1002/adfm.202300218
|View full text |Cite
|
Sign up to set email alerts
|

An Activity‐Based Nanosensor for Minimally‐Invasive Measurement of Protease Activity in Traumatic Brain Injury

Abstract: Current screening and diagnostic tools for traumatic brain injury (TBI) have limitations in sensitivity and prognostication. Aberrant protease activity is a central process that drives disease progression in TBI and is associated with worsened prognosis, thus direct measurements of protease activity can provide more diagnostic information. In this study, a nanosensor is engineered to release a measurable signal into the blood and urine in response to activity from the TBI‐associated protease calpain. Readouts … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 70 publications
0
1
0
Order By: Relevance
“…Curiously, ABPP has not yet been explored in human TBI samples for the development of diagnostic tools or eventual drug targets based on the biological activity of enzymes following TBI. Yet, the single protease activity of thrombin[6] or calpain 1 has already been explored via specific substrates or activity based sensors[10, 29], confirming that enzyme biological activity, but not protein abundance, plays a key role in molecular changes shortly after brain trauma. Currently, profiling of enzyme activity states by large-scale ABPP is usually performed in full cell lysates or in tissue homogenates[13, 23, 30] at physiological pH.…”
Section: Article Type: Rapid Communicationsmentioning
confidence: 99%
“…Curiously, ABPP has not yet been explored in human TBI samples for the development of diagnostic tools or eventual drug targets based on the biological activity of enzymes following TBI. Yet, the single protease activity of thrombin[6] or calpain 1 has already been explored via specific substrates or activity based sensors[10, 29], confirming that enzyme biological activity, but not protein abundance, plays a key role in molecular changes shortly after brain trauma. Currently, profiling of enzyme activity states by large-scale ABPP is usually performed in full cell lysates or in tissue homogenates[13, 23, 30] at physiological pH.…”
Section: Article Type: Rapid Communicationsmentioning
confidence: 99%